Analysis of margin classification systems for assessing the risk of local recurrence after soft tissue sarcoma resection by Gundle, Kenneth R. et al.
JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T
Analysis of Margin Classiﬁcation Systems for Assessing the
Risk of Local Recurrence After Soft Tissue Sarcoma Resection
Kenneth R. Gundle, Lisa Kafchinski, Sanjay Gupta, Anthony M. Grifﬁn, Brendan C. Dickson, Peter W. Chung,
Charles N. Catton, Brian O’Sullivan, Jay S. Wunder, and Peter C. Ferguson
A B S T R A C T
Purpose
To compare the ability of margin classiﬁcation systems to determine local recurrence (LR) risk after
soft tissue sarcoma (STS) resection.
Methods
Two thousand two hundred seventeen patients with nonmetastatic extremity and truncal STS
treated with surgical resection and multidisciplinary consideration of perioperative radiotherapy
were retrospectively reviewed. Margins were coded by residual tumor (R) classiﬁcation (in which
microscopic tumor at inked margin deﬁnes R1), the R+1mm classiﬁcation (in which microscopic
tumor within 1 mm of ink deﬁnes R1), and the Toronto Margin Context Classiﬁcation (TMCC; in
which positive margins are separated into planned close but positive at critical structures, positive
after whoops re-excision, and inadvertent positive margins). Multivariate competing risk regression
models were created.
Results
By R classiﬁcation, LR rates at 10-year follow-up were 8%, 21%, and 44% in R0, R1, and R2,
respectively. R+1mm classiﬁcation resulted in increased R1 margins (726 v 278, P , .001), but led
to decreased LR for R1margins without changing R0 LR; for R0, the 10-year LR rate was 8% (range,
7% to 10%); for R1, the 10-year LR ratewas 12% (10% to 15%) . The TMCC also showed various LR
rates among its tiers (P , .001). LR rates for positive margins on critical structures were not dif-
ferent from R0 at 10 years (11% v 8%, P = .18), whereas inadvertent positive margins had high LR
(5-year, 28% [95% CI, 19% to 37%]; 10-year, 35% [95% CI, 25% to 46%]; P , .001).
Conclusion
The R classiﬁcation identiﬁed three distinct risk levels for LR in STS. An R+1mm classiﬁcation
reduced LR differences between R1 and R0, suggesting that a negative but, 1-mmmargin may be
adequate with multidisciplinary treatment. The TMCC provides additional stratiﬁcation of positive
margins that may aid in surgical planning and patient education.
J Clin Oncol 36. © 2018 by American Society of Clinical Oncology
INTRODUCTION
A positive surgical margin after resection of ex-
tremity soft tissue sarcoma (STS) is awell-established
risk factor for local recurrence (LR).1-3 When local
control fails, subsequent treatments lead to addi-
tional morbidity and higher rates of amputation.4,5
Several large series, although not all, report that LR is
also associated with decreased overall survival.5-7
Despite the importance of a negative surgical mar-
gin to maximize local control of STS, there is sig-
niﬁcant variability in how margins are reported.8
Various systems exist for the classiﬁcation
of surgical margins. Before modern multiplane
imaging and the widespread use of adjuvant ra-
diation, a system by Enneking et al9 for describing
STS resection margins described intralesional,
marginal, wide, and radical margins, and noted
improved local control through radical resections.
Modern imaging and adjuvant radiotherapy fa-
cilitate successful functional limb salvage, often
with margins that would be classiﬁed as marginal
in the Enneking system.10-12 Use of the American
Joint Committee on Cancer (AJCC) residual
tumor classiﬁcation (R classiﬁcation) is reported
increasingly in sarcoma studies.8 The AJCC
manual describes an R0 margin as free of ma-
lignancy, an R1 margin is deﬁned as microscopic
tumor cells present at the inked border of the
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specimen, and R2 refers to a grossly positive margin. Several
studies of surgical margins in extremity STS have used this deﬁ-
nition and found it prognostic for LR.3,13,14 Other authors have
deﬁned a surgical margin of, 1mm from tumor asmicroscopically
positive; this system has likewise been reported as prognostic for
LR.4,15
Separate from the distance-based R classiﬁcation, two reports
have determined that the context of a positive margin inﬂuences
local control.13,16 With appropriate multidisciplinary discussion
and adjuvant radiotherapy, planned close but ultimately positive
margins around critical structures had LR rates similar to those
when critical structures were resected.11,13,16 Unexpected positive
margins after a tumor resection, referred to as inadvertent
positive margins (IPMs), had the lowest rates of local control.17
Current guidelines recommend complete resection of STS
with a negative surgical margin, without a speciﬁc recommen-
dation for the width of that margin or a standard deﬁnition of
a negative margin.18 Inconsistent reporting of outcomes impedes
comparative research, particularly for rare diseases. An ideal
margin classiﬁcation systemwould be prognostic for LR and would
be reproducible, to facilitate communication among clinicians and
researchers. The question of which margin classiﬁcation scheme
best determines LR risk remains unanswered. Therefore, the
purpose of this study was to compare three margin classiﬁcation
systems on the basis of their ability to discriminate the risk of LR
among classiﬁcation groups. The primary outcome was the cu-
mulative probability of LR, with death as a competing risk.
METHODS
After research ethics board approval, we retrieved clinical and pathologic
data from an institutional prospective STS database at a single tertiary
center. Patients with STS treated surgically between 1989 and 2014 were
eligible. Patients with dermatoﬁbrosarcoma protuberans (n = 35), well-
differentiated liposarcoma (n = 109), or metastatic disease at presentation
(n = 171) were excluded. Patients with tumors located in the extremities,
chest and abdominal wall, or paraspinal region were included; those with
tumors in the abdominal cavity, retroperitoneum, or head and neck were
excluded. The study group comprised 2,217 patients who were thus
identiﬁed.
Margin status for each system was retrieved or determined from
records. For the R classiﬁcation, the margin was categorized either as
grossly positive (R2), microscopically positive if tumor was at the inked
surface (R1), or microscopically negative if there was no tumor at the inked
surface (R0). For the R+1mm classiﬁcation, the R2 category was un-
changed; for specimens to be considered microscopically negative, there
had to be at least 1 mm of normal tissue between the tumor and the inked
border (R0), whereas specimens with tumor within 1 mm of the inked
border were categorized as microscopically positive (R1). For the Toronto
Margin Context Classiﬁcation (TMCC), tumor resections were classiﬁed
into four categories—negative margins (R0 according to the R classiﬁ-
cation); IPMs; planned close but with an ultimately positive microscopic
margin along a critical structure; and positive margin after a tumor bed re-
excision in patients treated initially with inadequate surgery elsewhere (the
whoops procedure).13,16 IPMs were deﬁned as an unexpected positive
margin result during a primary resection, and the margin status was
classiﬁed as planned close but ultimately positive only when it occurred
along a major bone, blood vessel, or nerve as part of the planned mul-
tidisciplinary treatment.
Treatment decisions were reviewed and ﬁnalized at a weekly mul-
tidisciplinary sarcoma tumor board. Surgery alone was used when a wide
resection of at least 1 cm of circumferential normal tissue, or else intact
fascia, could be obtained without removing critical structures. Otherwise,
radiation therapy was used before or after surgery. Generally, critical
neurovascular structures were not resected unless they were completely
encased by tumor. Chemotherapy was administered in a minority of cases
at the discretion of the multidisciplinary tumor board or as part of ongoing
trials. Tumors were graded according to French Federation of Cancer
Centers Sarcoma Group (FNCLCC)–criteria.
After surgery, follow-up for patients consisted of visits every
3 months for the ﬁrst 2 years, every 6 months from year 2 to year 5, then
annually until year 10. Surveillance consisted of chest imaging and ex-
amination of the wound and locoregional lymph nodes. Advanced imaging
was not obtained routinely unless there was clinical concern for recurrence.
The primary end point of the analysis was LR. Analyses were
completed with a competing risks framework. Death and metachronous
distant metastases, whichever occurred ﬁrst, were regarded as competing
events. Crude cumulative incidence was estimated for LR. To obtain the
estimated cumulative incidence of recurrence, we used a multivariate Fine
and Gray model and calculated subdistribution hazard ratios (HRs) for the
ﬁnal predictor variables.19-21 This method accounts for the risk of me-
tastasis or death when estimating the effects of covariates on LR, similar to
a Cox proportional model for univariate analyses. Several predictor var-
iables (patient age, tumor size, FNCLCC grade, tumor depth, and margin
status with each system) were predeﬁned and were applied in a backward
procedure using the Akaiki information criterion for variable selection.
Statistical analyses were completed in R version 3.2.2, including the cmprsk
package from the Comprehensive R Archive Network.21 This study was
designed and reported using Strengthening the Reporting of Observation
Studies in Epidemiology–criteria.22
RESULTS
A total of 2,217 patients with STS who met the inclusion criteria
were identiﬁed. Patient characteristics are listed in Table 1. The
median age was 57 years (range, 13 to 97 years), and most tumors
were high grade (54%) and deep (68%). Inadequate surgery before
presentation occurred in 853 patients (38%). Use of radiotherapy
was common (67%), with radiation administered preoperatively in
1,088 patients (49%), postoperatively in 330 patients (15%), and
both before and after operative treatment in 74 patients (3%). Few
patients received chemotherapy (18%). By the R classiﬁcation,
1,908 tumors (86%) were resected with a microscopically negative
margin. However, with the R+1mm system, the number of mi-
croscopically negative resections dropped to 1,459 (66%), with
a corresponding increase in the number of microscopically positive
resections (278 to 726, P , .001). Grossly positive margins were
rare (26 for each system [1%]).
At a mean follow-up of 65 months (range, 0.3 to 309 months),
the crude cumulative probability of LR at 5 years was 8% (95% CI,
7% to 9%) and the crude cumulative probability of LR at 10 years
was 10% (95% CI, 9% to 12%). The three margin classiﬁcation
systems were all able to determine various levels of risk, as sum-
marized in Table 2 (P , .001, Wald test). At 10 years, the prob-
ability of LR was 8% for R0, 21% for R1, and 44% for R2 resections
using the R classiﬁcation system. These values differed signiﬁcantly
from one another (P , .001). With the R+1mm classiﬁcation, the
probability of LR for R1 resections dropped to 12% without
changing LR rates for those with the stricter deﬁnition of R0 (Table 2
and Fig 1). According to the TMCC, there were four distinct levels
of risk on the basis of margin context. At 10 years the cumulative
2 © 2018 by American Society of Clinical Oncology JOURNAL OF CLINICAL ONCOLOGY
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probably of LR was 8% for negative margins, 11% for planned close
but ultimately positive margins at critical structures, 24% for
positive margins after tumor bed re-excision after a whoops pro-
cedure, and 35% for IPMs (P , .001; Fig 2).
In Fine and Gray subdistribution hazards modeling, variables
of age, sex, tumor location, and tumor size were eliminated,
whereas grade, depth, and the use of radiotherapy were included
with each margin system (Table 3). The effect of grade, depth, and
use of radiotherapy was similar for eachmargin system’s model and
these effects are reported together. Grade 2 STS did not have
a robust effect on LR (P = .11), but grade 3 tumors weremore likely
to recur (P = .02). Depth was also maintained as a predictor of LR
(HR, 1.5; P = .03). The use of radiotherapy reduced the risk of LR
by one half (P , .001).
With the R classiﬁcation, both R1 (HR, 3.2) and R2 (HR, 7.6)
were robustly signiﬁcant hazards for LR. In the R+1mm classiﬁ-
cation, an R1 margin was less predictive of recurrence, with
a hazard of 1.8 and a 95% CI ranging from 1 to 3.2 (P , .001).
In the 451 cases in which themargin changed fromR0 to R1 in
the R+1mm classiﬁcation system, there was a cumulative LR
probability of 6% (95% CI, 5% to 7%) at 5 years and 7% (95% CI,
6% to 8%) at 10 years. Grouped separately, these cases with
, 1 mm of normal tissue from tumor on microscopic analysis
had no signiﬁcantly different risk of LR than did R0 cases (sub-
distribution hazard, 1.1 [95% CI, 0.9 to 1.3]; P = .71) and were
signiﬁcantly less likely than the remaining R1 cases to have LR
(subdistribution hazard, 0.34 [95%CI, 0.1 to 0.58]; P, .001; Fig 3).
As in the cumulative probability plots, each margin context
category in the TMCC was associated with particular hazards for
LR. A planned close but ultimately positive margin at a critical
structure did not signiﬁcantly increase the risk of a LR when com-
pared with a negative microscopic margin (subdistribution hazard,
1.6; P = .18). A positive margin after tumor bed re-excision af-
ter a whoops procedure raised the hazard for LR (HR, 3.9; P, .001),
but the greatest hazard was associated with an IPM (HR, 5.7;
P , .001).
Sensitivity analyses included testing with only those patients
who received preoperative radiation. There were no substantial
changes in the results.
DISCUSSION
In this study, we show that the R classiﬁcation of surgical
margins is able to identify three distinct levels of LR risk in
patients after surgical treatment of STS. Patients with, 1 mm of
normal tissue microscopically from margin to tumor did not
have an elevated risk of LR. In addition, a margin context classi-
ﬁcation was able to determine low- and high-LR probability–
positive margins in a competing risk analysis. If externally validated,
more uniform collection and reporting of margins may aid in
communication with patients as well as among clinicians and
researchers.
Table 2. Cumulative Incidence of Soft Tissue Sarcoma Local Recurrence on
the Basis of Margin System Categorizations
Characteristic
5-Year LR
(%)
95% CI
(%)
10-Year LR
(%)
95% CI
(%) P
R classiﬁcation
R0 6 5 to 7 8 7 to 9 , .001
R1 17 12 to 21 21 16 to 26
R2 38 20 to 57 44 23 to 64
R+1mm
classiﬁcation
R0 6 5 to 7 8 7 to 10 , .001
R1 10 8 to 13 12 10 to 15
R2 38 20 to 57 44 23 to 64
TMCC
Negative 6 5 to 7 8 7 to 9 , .001
Planned close 10 5 to 17 11 6 to 19
Positive after
whoops
18 11 to 27 24 15 to 34
IPM 28 19 to 37 35 25 to 46
NOTE. Signiﬁcant statistical comparisons within each classiﬁcation system by
Wald test are denoted by the P value.
Abbreviations: IPM, inadvertent positive margin; LR, local recurrence; TMCC,
Toronto Margin Context Classiﬁcation.
Table 1. Clinicopathologic and Treatment Characteristics of Patients With Soft
Tissue Sarcoma (N = 2,217)
Characteristic No. (%)
Age, years
Median 57
Range 13-97
Sex
Female 979 (44)
Male 1,238 (56)
Tumor depth
Deep 1,515 (68)
Superﬁcial 697 (31)
Maximum tumor diameter, cm
Median 6.7
Range 0.5-39.5
Surgical margins
R classiﬁcation
R0 1,908 (86)
R1 278 (13)
R2 26 (1)
R+1mm classiﬁcation
R0 1,459 (66)
R1 726 (33)
R2 26 (1)
TMCC
Negative 1,908 (86)
Planned close 103 (5)
Positive after whoops 116 (5)
IPM 90 (4)
FNCLCC grade
1 282 (13)
2 709 (32)
3 1,193 (54)
Chemotherapy
Administered 408 (18)
Not administered 1,804 (81)
Radiotherapy
Administered 1,492 (67)
Not administered 706 (32)
Follow-up, months
Mean 65
Range 0.3-309
NOTE. Data are presented as No. (%) unless indicated otherwise.
Abbreviations: FNCLCC, French Federation of Cancer Centers Sarcoma Group;
IPM, inadvertent positive margin; TMCC, Toronto Margin Context Classiﬁcation.
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Although the R classiﬁcation designates a microscopically
positive margin (R1) as the presence of tumor cells at the inked
border, others have required 1mm of normal tissue between tumor
and margin to deﬁne a microscopically negative margin.4,13 This
R+1mm classiﬁcation is one of the varied, nonstandardized means
of outcomes reporting in the sarcoma community.8 Requiring an
additional 1 mm of normal tissue between the inked margin and
the tumor results in more resections being considered micro-
scopically positive. However, doing so did not lower the risk of LR
among the remaining microscopically negative resections when
comparedwith the standard R classiﬁcation. Patients with a, 1-mm
margin of normal tissue between the inked specimen and tumor
have an LR rate lower than the R classiﬁcation scheme’s deﬁnition
of R1 and similar to that of patients considered R0.
Finally, because the goal of margin classiﬁcation is to help
inform the risk of LR and perhaps guide surveillance, having three
clear levels of risk within the R classiﬁcation is more discriminative
than the relatively similar cumulative incidence curves seen with
the R+1mm classiﬁcation (Fig 1). This contrasts with the results of
Kainhofer et al,15 who in a study of 265 patients with STS and using
a Kaplan-Meier analysis for LR, showed lower rates of LR by
requiring an additional 1 mm of margin. This discrepancy may
result from incorporating the competing risk of death3 in the
current study, or other factors.
In a retrospective review of 111 patients after resection of STS,
McKee et al23 re-examined pathology slides and separated margin
distance into microscopic positive, 1 to 9 mm, and. 10 mm. They
demonstrated an overall 26% rate of LR; at 5 years, 84% (95% CI,
74% to 94%) of patients were free of LR with . 10-mm margins,
compared with 58%with either 1- to 9-mmmargins (95%CI, 40%
to 74%) or a positive margin (95% CI, 30% to 86%). Although the
authors concluded that a margin measuring , 10 mm was as-
sociated with an increased risk of LR, this may reﬂect the low rate
of adjuvant radiotherapy of 38% (including 39% for patients with
AJCC stage III STS) used in their sample, compared with 67% in
this study. The importance of radiotherapy was clearly demon-
strated in our study, with a HR of 0.5 for LR in those patients
receiving radiation. Biologically, this strong effect of radiotherapy
may reﬂect the impact of sarcoma cells being found up to 4 cm
away from the tumor mass in nonradiated specimens.24
Measuring the closest distance from tumor to margin is at best
an incomplete assessment of the three-dimensional boundary
between tumor and normal or reactive tissue. This study also
included a margin context classiﬁcation system, which previously
reported a prognostically signiﬁcant difference in outcome and
provides the rationale for close dissection to spare critical
structures.13,16 In this competing risks model, with frequent
perioperative radiotherapy, a planned close but ultimately positive
margin along ﬁxed critical structures such as bone or a major
neurovascular bundle was not associated with an increased hazard
for LR. In contrast, IPMs led to the highest risk of recurrence.17
Not all positive margins carry the same relative risk of LR. When
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Fig 1. Cumulative probability of local re-
currence by (A) R classiﬁcation and (B)
R+1mm classiﬁcation.
0 30 60 90 120
0.0
0.2
0.4
Time (months)
Cu
m
ul
at
iv
e 
Pr
ob
ab
ili
ty
Group
Negative margin
IPM
Planned close, ultimately positive
Positive after whoops re-excision
Fig 2. Cumulative probability of local recurrence by Toronto Margin Context
Classiﬁcation. IPM, inadvertent positive margin.
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the context of a positive margin is known, additional risk strati-
ﬁcation is possible.
The R classiﬁcation in either form does not take into account
the tissue type in which a margin resides. The Japanese Orthopedic
Association published an alternative margin classiﬁcation sys-
tem, but it requires documentation of information that was not
available for this study.2,25 It intuitively includes an assessment
of the tissue context when calculating a margin’s distance
equivalent, to reﬂect the resistance to tumor spread through
structures such as thick fascia and cartilage. Although rational
and useful for operative planning, especially in practice settings
keen to avoid the use of adjuvant radiotherapy,26 this system is
complex. Given the current lack of any consistent margin
reporting system in more than one third of published sarcoma
papers, a system that is simple and reproducible is more
advisable.8
This study has a number of limitations. First, it is a ret-
rospective analysis that is based on prospectively collected
data from a single center, and its conclusions would be
strengthened if validated by additional data samples. Second,
margin determinations were recorded from pathology reports
rather than readjudication, or prospective monitoring, and
the possibility of tumor sampling error exists.27 Local in-
stitutional practices regarding the use of neoadjuvant and
adjuvant therapies and surgical techniques likely also inﬂu-
ence outcomes, which limits the generalizability of these
ﬁndings.
By direct comparison of three schemes for classifying the
margin status in 2,217 patients with nonretroperitoneal STS at
one center, we found that the R classiﬁcation best determined
the risk of LR via a competing risks framework. Deﬁning an
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Fig 3. Cumulative probability of local re-
currence by R classiﬁcation, separating those
with , 1-mm margins.
Table 3. Results of the Fine and Gray Subdistribution Hazards for Local
Recurrence in Soft Tissue Sarcoma
Variable HR 95% CI (%) P
FNCLCC grade
2 v 1 1.6 0.9 to 3 .110
3 v 1 2.0 1.1 to 3.6 .020
Depth
Deep v superﬁcial 1.5 1.1 to 2.2 .030
Radiotherapy
Used v not used 0.5 0.3 to 0.6 , .001
R classiﬁcation
R1 v R0 3.2 2.3 to 4.6 , .001
R2 v R0 7.6 3.9 to 14.7 , .001
R+1mm classiﬁcation
R1 v R0 1.8 1 to 3.2 , .001
R2 v R0 7.6 3.9 to 14.9 , .001
TMCC
Planned close v R0 1.6 0.8 to 2.9 .180
After whoops v R0 3.9 2.3 to 6.6 , .001
IPM v R0 5.7 3.7 to 8.6 , .001
NOTE. Signiﬁcant statistical comparisons within each classiﬁcation system are
denoted by the P value.
Abbreviations: HR, hazard ratio; FNCLCC, French Federation of Cancer Centers
Sarcoma Group; IPM, inadvertent positive margin; TMCC, Toronto Margin
Context Classiﬁcation.
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R1-positive microscopic margin as tumor at the inked border
outperformed the concept of requiring at least 1 mm of normal
tissue between the inked specimen and tumor. However, the
margin context classiﬁcation system (TMCC) further categorized
high- and low-risk positive margins. More consistent margin status
reporting could aid in collaboration, patient education, and di-
rected surveillance.
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